ARTICLE | Clinical News
Xience Xpedition Everolimus Eluting Coronary Stent System regulatory update
May 27, 2013 7:00 AM UTC
Abbott received CE Mark approval for a 48 mm length of its Xience Xpedition Everolimus Eluting Coronary Stent System to treat coronary artery disease (CAD). The product is now available in Europe with...